Inhibition of proliferation, viability, migration and invasion of gastric cancer cells by Aurora-A deletion

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 10, 2011, Pages 2717-2720

  Wang, Wei ^a   Zhang, Ning ^a   Wang, Jian ^a   Bu, Xian Min ^a   Zhao, Cheng Hai ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Aurora A; Gastric cancer cells; Proliferation; Viability; VX 680

Indexed keywords

EID: 84863235418     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bar-Shira A, Pinthus JH, Rozovsky U, et al (2002). Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Cancer Res, 62, 6803-7.
2. Bischoff J R, Anderson L, Zhu Y, et al (1998). A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J, 17, 3052-65.
3. Carmena M, Earnshaw WC (2003). The cellular geography of aurorakinases. Nat Rev Mol Cell Biol, 4, 842-54.
4. Carvajal R, Tse A, Schwartz GK (2006). Aurora kinases: new targets for cancer therapy. Clin Cancer Res, 12, 6869-75.
5. Cheetham G, Charlton PA, Golec JM, et al (2007). Structural basis for potent inhibition of the Aurora kinases and a T315I multi-drug resistant mutant form of Abl kinase by VX-680. Cancer Lett, 251, 323-9.
6. Chen SS, Chang PC, Cheng YW, et al (2002). Suppression of the STK15 oncogenic activity requires a transactivation-independent p53 function. EMBO J, 21, 4491-9.
7. Dutertre S, Cazales M, Quaranta M, et al (2004). Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2-M transition. J Cell Sci, 117, 2523-31.
8. Giet R, Petretti C, Prigent C (2005). Aurora kinases, aneuploidy and cancer, a coincidence or a real link? Trends Cell Biol, 15, 241-50.
9. Jeng YM, Peng SY, Lin CY, et al (2004). Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res, 10, 2065-71.
10. Katayama H, Sasai K, Kawai H, et al (2004). Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet, 36, 55-62.
11. Keen N, S Taylor (2006). Aurora-kinase inhibitors as anticancer agents. Nat Rev Cancer, 4, 927-36.
12. Li D, Zhu J, Firozi PF, et al (2003). Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res, 9, 991-7.
13. Marumoto T, Zhang D, Saya H (2005). Aurora-A a guardian of poles. Nat Rev Cancer, 5, 42-50.
14. Meraldi P, Honda R, Nigg EA (2004). Aurora kinases link chromosome segregation and cell division to cancer susceptibility. Curr Opin Genet Dev, 14, 29-36.
15. Moreno-Bueno G, Sánchez-Estévez C, Cassia R, et al (2003). Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. Cancer Res, 63, 5697-702.
16. Neben K, Korshunov A, Benner A, et al (2004). Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. Cancer Res, 64, 3103-11.
17. Nigg EA (2001). Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol, 2, 21-32.
18. Reichardt W, Jung V, Brunner C, et al (2003). The putative serine/threonine kinase gene STK15 on chromosome 20q13.2 is amplified in human gliomas. Oncol Rep, 10, 1275-9.
19. Sakakura C, Hagiwara A, Yasuoka R, et al (2001). Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br J Cancer, 84, 824-31.
20. Sen S, Zhou H, White RA (1997). A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene, 14, 2195-200.
21. Sen S, Zhou H, Zhang RD, et al (2002). Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst, 94, 1320-9.
22. Warner S, Munoz RM, Stafford P, et al (2006). Comparing Aurora A and Aurora B as molecular targets for growth inhibition of pancreatic cancer cells. Mol Cancer Ther, 5, 2450-8.
23. Weidner N (1995). Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol, 147, 9-19.
24. Whelan SL(1993). Trends in Cancer Incidence and Mortality. IARC Lyon, IARC Scientific Publ No 102.
25. Wu JC, Chen TY, Yu CT, et al (2005). Identification of V23RalA-Ser194 as a critical mediator for Aurora-A-induced cellular motility and transformation by small pool expression screening. J Biol Chem, 280, 9013-22.
26. Xin Y, Li XL, Wang YP, et al (2001). Relationship between phenotypes of cell-function differentiation and pathobiological behavior of gastric carcinomas. World J Gastroenterol, 7, 53-9.
27. Yang H, Burke T, Dempsey J, et al (2005). Mitotic requirement for Aurora A kinase is bypassed in the absence of Aurora B kinase. FEBS Lett, 579, 3385-91.
28. Zhou H, Kuang J, Zhong L, et al (1998). Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet, 20, 189-93.